Stanford University
Showing 7,621-7,640 of 36,323 Results
-
Sibyl Diver
Lecturer
BioDr. Sibyl Diver is an interdisciplinary environmental scientist, a lecturer at Stanford University in the Earth Systems Program, and co-director for the Stanford Environmental Justice Working Group. She does community-engaged research on Indigenous water governance from an allied perspective, focusing on Pacific Northwest salmon watersheds. This includes research on co-management (or collaborative management) arrangements between Indigenous communities and state agencies. She received her PhD from Berkeley's Department of Environmental Science, Policy and Management, where she helped build the Karuk-UC Berkeley Collaborative, a group supporting the Karuk Tribe's eco-cultural revitalization strategy in Northern California. Current work includes conducting a social impact assessment of Klamath dam removal with the Karuk Tribe.
For over two decades, Sibyl has worked in partnership with community leaders on issues of Indigenous peoples and salmon around the North Pacific – in the Russian Far East, Alaska, Canada and the US. Previous to graduate school, she spent eight years doing international conservation work and facilitating international exchanges with community leaders as a Russian translator -- an experience that introduced her to the deep connections between salmon conservation and Indigenous peoples. She completed her undergraduate work at Stanford, earning a dual degree in Human Biology and Slavic Studies.
For additional research information please see www.sibyldiver.com. -
Vasu Divi, MD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS)
BioDr. Vasu Divi is a distinguished expert in the field of head and neck cancer treatment, renowned for his dual roles as a cancer surgeon and reconstructive surgeon. With a specialized focus on high-risk and advanced skin cancers, oral cavity cancers, and osteoradionecrosis of the head and neck, Dr. Divi stands at the forefront of medical innovation. As a national authority in cutaneous squamous cell carcinoma of the head and neck, Dr. Divi spearheads Stanford's clinical trial program dedicated to this condition. His trial portfolio encompasses both neoadjuvant and adjuvant applications of immunotherapy, reflecting his commitment to advancing treatment methodologies. Actively engaged in research, Dr. Divi endeavors to define the optimal treatment approach for this disease, integrating immunotherapy to enhance patient outcomes.
-
Anjali Dixit, MD, MPH
Instructor, Anesthesiology, Perioperative and Pain Medicine
BioI am a pediatric anesthesiologist and health services researcher. My research focuses on outcomes in pediatric and adult surgical patients, management of pain and use of opioids in the perioperative period, and prevention and treatment of substance use disorders. My clinical care and research are both grounded in a desire to provide safe, equitable healthcare to all patients, particularly during high-risk or stressful events such as surgery.
-
Lance Dixon
Professor of Particle Physics and Astrophysics, Emeritus
Current Research and Scholarly InterestsI am interested in novel descriptions of how relativistic particles scattering, and how those insights can be applied to a variety of problems. Applications include precision QCD for the Large Hadron Collider; scattering in "toy models" such as N=4 super-Yang-Mills theory where an all orders solution seems feasible in the planar limit; the ultraviolet structure of quantum gravity; and problems in classical gravity such as gravitational radiation from compact binary inspiral.
-
Scott Dixon
Professor of Biology
Current Research and Scholarly InterestsMy lab is interested in the relationship between cell death and metabolism. Using techniques drawn from many disciplines my laboratory is investigating how perturbation of intracellular metabolic networks can result in novel forms of cell death, such as ferroptosis. We are interested in applying this knowledge to find new ways to treat diseases characterized by insufficient (e.g. cancer) or excessive (e.g. neurodegeneration) cell death.
